Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety of low dose efavirenz regimen in Indian adults with HIV-1 infection: Insights from a phase 4 interventional randomised trial.
Medicine (Baltimore). 2023 Nov 3;102(44):e35643. doi: 10.1097/MD.0000000000035643.
Medicine (Baltimore). 2023.
PMID: 37933062
Free PMC article.
Clinical Trial.
An Extract of Glycyrrhiza glabra (GutGard) Alleviates Symptoms of Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study.
Raveendra KR, Jayachandra, Srinivasa V, Sushma KR, Allan JJ, Goudar KS, Shivaprasad HN, Venkateshwarlu K, Geetharani P, Sushma G, Agarwal A.
Raveendra KR, et al.
Evid Based Complement Alternat Med. 2012;2012:216970. doi: 10.1155/2012/216970. Epub 2011 Jun 16.
Evid Based Complement Alternat Med. 2012.
PMID: 21747893
Free PMC article.
Item in Clipboard
Effect of NR-Salacia on post-prandial hyperglycemia: A randomized double blind, placebo-controlled, crossover study in healthy volunteers.
Koteshwar P, Raveendra KR, Allan JJ, Goudar KS, Venkateshwarlu K, Agarwal A.
Koteshwar P, et al. Among authors: raveendra kr.
Pharmacogn Mag. 2013 Oct;9(36):344-9. doi: 10.4103/0973-1296.117831.
Pharmacogn Mag. 2013.
PMID: 24124287
Free PMC article.
Item in Clipboard
Salacia reticulata improves serum lipid profiles and glycemic control in patients with prediabetes and mild to moderate hyperlipidemia: a double-blind, placebo-controlled, randomized trial.
Shivaprasad HN, Bhanumathy M, Sushma G, Midhun T, Raveendra KR, Sushma KR, Venkateshwarlu K.
Shivaprasad HN, et al. Among authors: raveendra kr.
J Med Food. 2013 Jun;16(6):564-8. doi: 10.1089/jmf.2013.2751.
J Med Food. 2013.
PMID: 23767865
Clinical Trial.
Item in Clipboard
REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicenter, single-arm, Phase IV itolizumab Trial: RESURRECT.
Kr R, Rathod C, Darnule R, Loganathan S, Deodhar S, A R, Marwah A, Chaudhari NM, Thakur BK, Vaidyanathan S, Athalye SN.
Kr R, et al.
Expert Opin Biol Ther. 2023 May;23(5):443-454. doi: 10.1080/14712598.2023.2204186. Epub 2023 Apr 28.
Expert Opin Biol Ther. 2023.
PMID: 37073744
Item in Clipboard
Cite
Cite